Cargando…
Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies
Advances in molecular technologies have the potential to help remedy health inequities through earlier detection and prevention; if, however, their delivery and uptake (and therefore any benefits associated with such testing) are not more carefully considered, there is a very real risk that existing...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656149/ https://www.ncbi.nlm.nih.gov/pubmed/31911498 http://dx.doi.org/10.1136/medethics-2019-105734 |
_version_ | 1783608321459093504 |
---|---|
author | Filoche, Sara Stone, Peter Cram, Fiona Bacharach, Sondra Dowell, Anthony Sika-Paotonu, Dianne Beard, Angela Ormandy, Judy Buchanan, Christina Thunders, Michelle Dew, Kevin |
author_facet | Filoche, Sara Stone, Peter Cram, Fiona Bacharach, Sondra Dowell, Anthony Sika-Paotonu, Dianne Beard, Angela Ormandy, Judy Buchanan, Christina Thunders, Michelle Dew, Kevin |
author_sort | Filoche, Sara |
collection | PubMed |
description | Advances in molecular technologies have the potential to help remedy health inequities through earlier detection and prevention; if, however, their delivery and uptake (and therefore any benefits associated with such testing) are not more carefully considered, there is a very real risk that existing inequities in access and use will be further exacerbated. We argue this risk relates to the way that information and knowledge about the technology is both acquired and shared, or not, between health practitioners and their patients. A healthcare system can be viewed as a complex social network comprising individuals with different worldviews, hierarchies, professional cultures and subcultures and personal beliefs, both for those giving and receiving care. When healthcare practitioners are not perceived as knowledge equals, they would experience informational prejudices, and the result is that knowledge dissemination across and between them would be impeded. The uptake and delivery of a new technology may be inequitable as a result. Patients would also experience informational prejudice when they are viewed as not being able to understand the information that is presented to them, and information may be withheld. Informational prejudices driven by social relations and structures have thus far been underexplored in considering (in)equitable implementation and uptake of new molecular technologies. Every healthcare interaction represents an opportunity for experiencing informational prejudice, and with it the risk of being inappropriately informed for undertaking (or offering) such screening or testing. Making knowledge acquisition and information dissemination, and experiences of informational prejudice, explicit through sociologically framed investigations would extend our understandings of (in)equity, and offer ways to affect network relationships and structures that support equity in delivery and uptake. |
format | Online Article Text |
id | pubmed-7656149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-76561492020-11-17 Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies Filoche, Sara Stone, Peter Cram, Fiona Bacharach, Sondra Dowell, Anthony Sika-Paotonu, Dianne Beard, Angela Ormandy, Judy Buchanan, Christina Thunders, Michelle Dew, Kevin J Med Ethics Original Research Advances in molecular technologies have the potential to help remedy health inequities through earlier detection and prevention; if, however, their delivery and uptake (and therefore any benefits associated with such testing) are not more carefully considered, there is a very real risk that existing inequities in access and use will be further exacerbated. We argue this risk relates to the way that information and knowledge about the technology is both acquired and shared, or not, between health practitioners and their patients. A healthcare system can be viewed as a complex social network comprising individuals with different worldviews, hierarchies, professional cultures and subcultures and personal beliefs, both for those giving and receiving care. When healthcare practitioners are not perceived as knowledge equals, they would experience informational prejudices, and the result is that knowledge dissemination across and between them would be impeded. The uptake and delivery of a new technology may be inequitable as a result. Patients would also experience informational prejudice when they are viewed as not being able to understand the information that is presented to them, and information may be withheld. Informational prejudices driven by social relations and structures have thus far been underexplored in considering (in)equitable implementation and uptake of new molecular technologies. Every healthcare interaction represents an opportunity for experiencing informational prejudice, and with it the risk of being inappropriately informed for undertaking (or offering) such screening or testing. Making knowledge acquisition and information dissemination, and experiences of informational prejudice, explicit through sociologically framed investigations would extend our understandings of (in)equity, and offer ways to affect network relationships and structures that support equity in delivery and uptake. BMJ Publishing Group 2020-11 2020-01-07 /pmc/articles/PMC7656149/ /pubmed/31911498 http://dx.doi.org/10.1136/medethics-2019-105734 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Original Research Filoche, Sara Stone, Peter Cram, Fiona Bacharach, Sondra Dowell, Anthony Sika-Paotonu, Dianne Beard, Angela Ormandy, Judy Buchanan, Christina Thunders, Michelle Dew, Kevin Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title | Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title_full | Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title_fullStr | Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title_full_unstemmed | Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title_short | Uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
title_sort | uncovering social structures and informational prejudices to reduce inequity in delivery and uptake of new molecular technologies |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656149/ https://www.ncbi.nlm.nih.gov/pubmed/31911498 http://dx.doi.org/10.1136/medethics-2019-105734 |
work_keys_str_mv | AT filochesara uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT stonepeter uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT cramfiona uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT bacharachsondra uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT dowellanthony uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT sikapaotonudianne uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT beardangela uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT ormandyjudy uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT buchananchristina uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT thundersmichelle uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies AT dewkevin uncoveringsocialstructuresandinformationalprejudicestoreduceinequityindeliveryanduptakeofnewmoleculartechnologies |